Comprehensive assessment of the hemostatic system in women with РAI-1 gene polymorphism and first trimester pregnancy loss
DOI:
https://doi.org/10.15574/HW.2024.6(175).4349Keywords:
pregnancy, miscarriage, genetic polymorphisms, thrombophilia, early terms of gestation, natural anticoagulants, activity, hemostasisAbstract
Aim - to study the associations between hemostatic system parameters, natural anticoagulant levels and serum PAI-1 levels depending on the PAI-1 polymorphism variant in women with early reproductive losses.
Materials and methods. The selected patients (n=115) were divided into 3 groups according to the type of polymorphism: Clinical group I (n=20) - patients with wild-type polymorphism of the РAI-1 gene (675 5G>5G), group II (n=53) - women with heterozygous polymorphism of the РAI-1 gene (675 5G>4G), group III (n=42) - women with homozygous pathological polymorphism of РAI-1 (675 4G>4G). The study was based on bibliosemantic analysis; anamnestic data were evaluated; polymerase chain reaction (PCR) was used to determine thrombophilia gene polymorphisms; enzyme-linked immunosorbent assay (ELISA) to determine the level of РAI-1 in the blood serum; clotting method to determine the levels of natural anticoagulants; coagulometric method to determine the level of fibrinogen and coagulation parameters.
Results. The average age of women in the thematic groups was comparable and amounted to 32.5±0.9, 33.9±0.7 and 33.6±0.7 years, respectively. The analysis of associations in the comprehensive assessment of haemostatic parameters revealed certain associations between these parameters and a complicated obstetric history (spontaneous abortion, fetal growth retardation and pre-eclampsia, pregnancy loss in early (more frequent) and late gestation), and the presence of РAI-1 gene polymorphism. No significant associations were found between the presence of the РAI-1 gene polymorphism and levels of natural anticoagulant activity. The level of РAI-1 depended on the type of polymorphism in this gene and was associated with termination of pregnancy before 12 weeks.
Conclusions. Polymorphisms of the PAI-1 gene should be considered as one of the risk factors for habitual miscarriage. Overexpression of PAI-1 is associated with adverse pregnancy complications, and its level is an extremely promising marker for prognosis and treatment effectiveness.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
References
Abbas Y, Turco MY, Burton GJ, Moffett A. (2020). Investigation of human trophoblast invasion in vitro. Hum. Reprod. Update. 26: 501-513. https://doi.org/10.1093/humupd/dmaa017; PMid:32441309 PMCid:PMC7473396
Aso Y. (2007). Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. Front Biosci. 12: 2957-2966. https://doi.org/10.2741/2285; PMid:17485272
Bastelica D, Morange P, Berthet B, Borghi H, Lacroix O, Grino M et al. (2002) Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol. 22: 173-178. https://doi.org/10.1161/hq0102.101552; PMid:11788479
Chen H, Nie S, Lu M. (2015) Association between Plasminogen Activator Inhibitor-1 Gene Polymorphisms and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis. Am J Reprod Immunol. 73 (4): 292-300. https://doi.org/10.1111/aji.12321; PMid:25250948
Chen Y, Budd RC, Kelm RJJ, Sobel BE, Schneider DJ. (2006) Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol. 26: 1777-1783. https://doi.org/10.1161/01.ATV.0000227514.50065.2a; PMid:16709941
Chen Y, Kelm RJJ, Budd RC, Sobel BE, Schneider DJ. (2004) Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1. J Cell Biochem. 92: 178-188. https://doi.org/10.1002/jcb.20058; PMid:15095413
Chen Y, Wu XX, Tan JP, Liu ML, Liu YL, Zhang JP. (2012) Effects of low molecular weight heparin and heparin-binding epidermal growth factor on human trophoblast in first trimester. Fertil Steril. 3: 70-74. https://doi.org/10.1016/j.fertnstert.2011.12.002; PMid:22222192
Duka YuM. (2016). Patohenetychne obhruntuvannia diahnostyky, likuvalnoi taktyky ta profilaktyky vynyknennia systemnykh porushen u vahitnykh zhinok z nadmirnoiu masoiu tila. Dys. … d-ra med. nauk. Dnipro,
Duka YuM. (2018). Materynska trombofiliia yak predyktor vynyknennia akusherskykh uskladnen ta perynatalnykh vtrat u zhinok iz nevynoshuvanniam vahitnosti zalezhno vid masy tila. Reproduktyvna endokrynolohyia. 42: 68-74. https://doi.org/10.18370/2309-4117.2018.42.68-74
Durand MK, Bodker JS, Christensen A, Dupont DM, Hansen M, Jensen JK et al. (2004) Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis. Thromb Haemost. 91: 438-449. https://doi.org/10.1160/TH03-12-0784; PMid:14983218
Hrechanyna EIa, Oleinyk DV. (2018) Obzor mutatsyy v hene PAI-1. Klinichna henetyka i perynatalna diahnostyka. 2018; 1(4): 42-47.
Jern C, Eriksson E, Tengborn L, Risberg B, Wadenvik H, Jern S.(1989) Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost. 62: 767-771. https://doi.org/10.1055/s-0038-1646899; PMid:2814924
Lemish, NY. (2024) Methodology for the prevention of major obstetric syndromes. Ukrainian Journal Health of Woman. 3(172): 43-48. https://doi.org/10.15574/HW.2024.172.43
Medved VI, Dubossarska YuO, Dubossarska ZM, Duka YuM. (2014). Profilaktyka akusherskykh ta trombotychnykh uskladnen u zhinok z trombofiliiamy. Metodychni rekomendatsii. Kyiv: 30.
Uchida Y, Ohba K, Yoshioka T, Irie K, Muraki T, Maru Y. (2004). Cellular carbonyl stress enhances the expression of plasminogen activator inhibitor-1 in rat white adipocytes via reactive oxygen species-dependent pathway. J. Biol Chem. 279: 4075-4083. https://doi.org/10.1074/jbc.M304222200; PMid:14610081
Yamamoto K, Takeshita K, Shimokawa T, Yi H, Isobe KI et al. (2002). Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stressinduced thrombosis in aged individuals. Proc Natl Acad Sci U S A. 99: 890-895. https://doi.org/10.1073/pnas.022608799; PMid:11792849 PMCid:PMC117401
Yushchenko MI, Duka YuM. (2023). Assessment of genetic susceptibility to the occurrence of placenta-associated complications in pregnant women with retrochorial hematomas in the trimester I of pregnancy. Ukrainian Journal of Perinatology and Pediatrics. 1(93): 12-18. https://doi.org/10.15574/PP.2023.93.12
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Ukrainian Journal Health of Woman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
